These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
Filed on March 23, 2022 |
|
Filed on March 26, 2021 |
|
Filed on March 21, 2019 |
|
Filed on March 20, 2018 |
|
Filed on March 21, 2017 |
|
ý
|
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
For the Quarterly Period Ended March 31, 2018
|
||
OR
|
||
o
|
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
Commission File Number 1-137533
|
Delaware
(State of Incorporation)
|
|
47-3936076
(I.R.S. Employer Identification No.)
|
Large accelerated filer
ý
|
|
Accelerated filer
o
|
|
Non-accelerated filer
o
(Do not check if a
smaller reporting company)
|
|
Smaller reporting company
o
|
|
Emerging growth company
o
|
Class
|
|
Outstanding at May 1, 2018
|
Common Stock, $0.01 par value per share
|
|
72,034,014 shares
|
|
TABLE OF CONTENTS
|
||||
|
||||
|
||||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|
||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
|
|
Three Months Ended March 31,
|
||||||
(In millions, except per share amounts)
|
2018
|
|
2017
|
||||
Net sales
|
$
|
250.2
|
|
|
$
|
225.3
|
|
Cost of goods sold
|
162.7
|
|
|
140.0
|
|
||
Gross profit
|
87.5
|
|
|
85.3
|
|
||
Selling, general and administrative expenses
|
74.9
|
|
|
72.8
|
|
||
Research and development expenses
|
4.9
|
|
|
4.8
|
|
||
Interest expense and related financing costs
|
13.8
|
|
|
17.0
|
|
||
Repositioning expenses
|
0.9
|
|
|
2.0
|
|
||
Restructuring and asset impairments
|
(0.5
|
)
|
|
1.1
|
|
||
Other (income) expense, net
|
(6.3
|
)
|
|
1.0
|
|
||
Total costs and expenses
|
87.7
|
|
|
98.7
|
|
||
Loss from continuing operations before income taxes
|
(0.2
|
)
|
|
(13.4
|
)
|
||
Income tax expense
|
(13.5
|
)
|
|
(11.6
|
)
|
||
Loss from continuing operations
|
(13.7
|
)
|
|
(25.0
|
)
|
||
Income from discontinued operations, net of income taxes
|
7.2
|
|
|
8.1
|
|
||
Net loss
|
(6.5
|
)
|
|
(16.9
|
)
|
||
Less: Net income attributable to noncontrolling interests
|
(0.1
|
)
|
|
—
|
|
||
Net loss attributable to GCP shareholders
|
$
|
(6.6
|
)
|
|
$
|
(16.9
|
)
|
Amounts Attributable to GCP Shareholders:
|
|
|
|
||||
Loss from continuing operations attributable to GCP shareholders
|
(13.8
|
)
|
|
(25.0
|
)
|
||
Income from discontinued operations, net of income taxes
|
7.2
|
|
|
8.1
|
|
||
Net loss attributable to GCP shareholders
|
$
|
(6.6
|
)
|
|
$
|
(16.9
|
)
|
(Loss) Earnings Per Share Attributable to GCP Shareholders
|
|
|
|
||||
Basic (loss) earnings per share:
|
|
|
|
||||
Loss from continuing operations attributable to GCP shareholders
|
$
|
(0.19
|
)
|
|
$
|
(0.35
|
)
|
Income from discontinued operations, net of income taxes
|
$
|
0.10
|
|
|
$
|
0.11
|
|
Net loss attributable to GCP shareholders
(1)
|
$
|
(0.09
|
)
|
|
$
|
(0.24
|
)
|
Weighted average number of basic shares
|
71.9
|
|
|
71.2
|
|
||
Diluted (loss) earnings per share:
(2)
|
|
|
|
||||
Loss from continuing operations attributable to GCP shareholders
|
$
|
(0.19
|
)
|
|
$
|
(0.35
|
)
|
Income from discontinued operations, net of income taxes
|
$
|
0.10
|
|
|
$
|
0.11
|
|
Net loss attributable to GCP shareholders
(1)
|
$
|
(0.09
|
)
|
|
$
|
(0.24
|
)
|
Weighted average number of diluted shares
|
71.9
|
|
|
71.2
|
|
(In millions, except par value and shares)
|
March 31,
2018 |
|
December 31,
2017 |
||||
ASSETS
|
|
|
|
||||
Current Assets
|
|
|
|
||||
Cash and cash equivalents
|
$
|
592.9
|
|
|
$
|
721.5
|
|
Trade accounts receivable, less allowance of $5.3 (2017—$5.7)
|
194.6
|
|
|
217.1
|
|
||
Inventories
|
114.6
|
|
|
106.3
|
|
||
Other current assets
|
46.3
|
|
|
48.6
|
|
||
Current assets held for sale
|
8.1
|
|
|
19.7
|
|
||
Total Current Assets
|
956.5
|
|
|
1,113.2
|
|
||
Properties and equipment, net
|
220.1
|
|
|
216.6
|
|
||
Goodwill
|
202.9
|
|
|
198.2
|
|
||
Technology and other intangible assets, net
|
91.1
|
|
|
91.8
|
|
||
Deferred income taxes
|
27.1
|
|
|
30.2
|
|
||
Overfunded defined benefit pension plans
|
27.9
|
|
|
26.4
|
|
||
Other assets
|
37.3
|
|
|
23.8
|
|
||
Non-current assets held for sale
|
2.0
|
|
|
2.8
|
|
||
Total Assets
|
$
|
1,564.9
|
|
|
$
|
1,703.0
|
|
LIABILITIES AND STOCKHOLDERS' EQUITY
|
|
|
|
||||
Current Liabilities
|
|
|
|
||||
Debt payable within one year
|
$
|
22.5
|
|
|
$
|
24.0
|
|
Accounts payable
|
133.7
|
|
|
134.8
|
|
||
Other current liabilities
|
192.5
|
|
|
316.2
|
|
||
Current liabilities held for sale
|
4.3
|
|
|
7.8
|
|
||
Total Current Liabilities
|
353.0
|
|
|
482.8
|
|
||
Debt payable after one year
|
520.4
|
|
|
520.3
|
|
||
Income taxes payable
|
53.9
|
|
|
58.3
|
|
||
Deferred income taxes
|
14.6
|
|
|
14.7
|
|
||
Unrecognized tax benefits
|
42.9
|
|
|
42.4
|
|
||
Underfunded and unfunded defined benefit pension plans
|
56.2
|
|
|
57.1
|
|
||
Other liabilities
|
19.1
|
|
|
35.1
|
|
||
Non-current liabilities held for sale
|
0.3
|
|
|
0.3
|
|
||
Total Liabilities
|
1,060.4
|
|
|
1,211.0
|
|
||
Commitments and Contingencies - Note 8
|
|
|
|
||||
Stockholders' Equity
|
|
|
|
||||
Common stock issued, par value $0.01; 300,000,000 shares authorized; outstanding: 71,995,738 and 71,754,344, respectively
|
0.7
|
|
|
0.7
|
|
||
Paid-in capital
|
35.3
|
|
|
29.9
|
|
||
Accumulated earnings
|
542.1
|
|
|
548.7
|
|
||
Accumulated other comprehensive loss
|
(71.4
|
)
|
|
(85.7
|
)
|
||
Treasury stock
|
(4.1
|
)
|
|
(3.4
|
)
|
||
Total GCP's Shareholders' Equity
|
502.6
|
|
|
490.2
|
|
||
Noncontrolling interests
|
1.9
|
|
|
1.8
|
|
||
Total Stockholders' Equity
|
504.5
|
|
|
492.0
|
|
||
Total Liabilities and Stockholders' Equity
|
$
|
1,564.9
|
|
|
$
|
1,703.0
|
|
|
Three Months Ended March 31,
|
||||||
(In millions)
|
2018
|
|
2017
|
||||
Net loss
|
$
|
(6.5
|
)
|
|
$
|
(16.9
|
)
|
Other comprehensive income:
|
|
|
|
||||
Currency translation adjustments
|
14.3
|
|
|
12.6
|
|
||
Total other comprehensive income
|
14.3
|
|
|
12.6
|
|
||
Comprehensive income (loss)
|
7.8
|
|
|
(4.3
|
)
|
||
Less: Comprehensive income attributable to noncontrolling interests
|
(0.1
|
)
|
|
—
|
|
||
Comprehensive income (loss) attributable to GCP shareholders
|
$
|
7.7
|
|
|
$
|
(4.3
|
)
|
|
Common Stock
|
|
Treasury Stock
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||
(In millions)
|
Number of Shares
|
|
Par Value
|
|
Number of Shares
|
|
Cost
|
|
Additional Paid-in Capital
|
|
Accumulated Earnings / (Deficit)
|
|
Accumulated Other Comprehensive Loss
|
|
Noncontrolling Interests
|
|
Total Stockholders' Equity (Deficit)
|
||||||||||||||||
Balance, December 31, 2016
|
71.2
|
|
|
$
|
0.7
|
|
|
0.1
|
|
|
$
|
(2.1
|
)
|
|
$
|
11.0
|
|
|
$
|
(4.7
|
)
|
|
$
|
(147.6
|
)
|
|
$
|
3.7
|
|
|
$
|
(139.0
|
)
|
Net loss
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(16.9
|
)
|
|
—
|
|
|
—
|
|
|
(16.9
|
)
|
|||||||
Issuance of common stock in connection with stock plans
|
0.1
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||||
Share-based compensation
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
2.1
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
2.1
|
|
|||||||
Exercise of stock options
|
0.3
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
4.1
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
4.1
|
|
|||||||
Treasury stock purchased under GCP 2016 Stock Incentive Plan
(1)
|
—
|
|
|
—
|
|
|
—
|
|
|
(0.9
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(0.9
|
)
|
|||||||
Other comprehensive income
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
12.6
|
|
|
—
|
|
|
12.6
|
|
|||||||
Dividends and other changes in noncontrolling interest
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
0.3
|
|
|
0.3
|
|
|||||||
Balance, March 31, 2017
|
71.6
|
|
|
$
|
0.7
|
|
|
0.1
|
|
|
$
|
(3.0
|
)
|
|
$
|
17.2
|
|
|
$
|
(21.6
|
)
|
|
$
|
(135.0
|
)
|
|
$
|
4.0
|
|
|
$
|
(137.7
|
)
|
Balance, December 31, 2017
|
71.9
|
|
|
$
|
0.7
|
|
|
0.1
|
|
|
$
|
(3.4
|
)
|
|
$
|
29.9
|
|
|
$
|
548.7
|
|
|
$
|
(85.7
|
)
|
|
$
|
1.8
|
|
|
$
|
492.0
|
|
Net (loss) income
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(6.6
|
)
|
|
—
|
|
|
0.1
|
|
|
(6.5
|
)
|
|||||||
Issuance of common stock in connection with stock plans
|
0.1
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||||
Share-based compensation
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
1.9
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
1.9
|
|
|||||||
Exercise of stock options
|
0.2
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
3.5
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
3.5
|
|
|||||||
Share repurchases
|
—
|
|
|
—
|
|
|
0.1
|
|
|
(0.7
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(0.7
|
)
|
|||||||
Other comprehensive income
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
14.3
|
|
|
—
|
|
|
14.3
|
|
|||||||
Balance, March 31, 2018
|
72.2
|
|
|
$
|
0.7
|
|
|
0.2
|
|
|
$
|
(4.1
|
)
|
|
$
|
35.3
|
|
|
$
|
542.1
|
|
|
$
|
(71.4
|
)
|
|
$
|
1.9
|
|
|
$
|
504.5
|
|
(1)
|
For the quarter ending March 31, 2017, GCP repurchased approximately
33,000
shares of Company common stock for
$0.9 million
in connection with its equity compensation programs; number of shares is not included in the table above due to rounding.
|
|
Three Months Ended March 31,
|
||||||
(In millions)
|
2018
|
|
2017
|
||||
OPERATING ACTIVITIES
|
|
|
|
||||
Net loss
|
$
|
(6.5
|
)
|
|
$
|
(16.9
|
)
|
Less: Income from discontinued operations
|
7.2
|
|
|
8.1
|
|
||
Loss from continuing operations
|
(13.7
|
)
|
|
(25.0
|
)
|
||
Reconciliation to net cash (used in) provided by operating activities:
|
|
|
|
||||
Depreciation and amortization
|
10.2
|
|
|
8.4
|
|
||
Amortization of debt discount and financing costs
|
0.5
|
|
|
0.8
|
|
||
Stock-based compensation expense
|
1.9
|
|
|
2.1
|
|
||
Currency and other losses in Venezuela
|
—
|
|
|
0.1
|
|
||
Deferred income taxes
|
9.5
|
|
|
8.5
|
|
||
Loss (gain) on disposal of property and equipment
|
(1.2
|
)
|
|
(0.8
|
)
|
||
Changes in assets and liabilities, excluding effect of currency translation:
|
|
|
|
||||
Trade accounts receivable
|
25.7
|
|
|
(0.4
|
)
|
||
Inventories
|
(7.3
|
)
|
|
(12.7
|
)
|
||
Accounts payable
|
(0.9
|
)
|
|
16.7
|
|
||
Pension assets and liabilities, net
|
(1.7
|
)
|
|
1.9
|
|
||
Other assets and liabilities, net
|
(31.5
|
)
|
|
(27.6
|
)
|
||
Net cash used in operating activities from continuing operations
|
(8.5
|
)
|
|
(28.0
|
)
|
||
Net cash (used in) provided by operating activities from discontinued operations
|
(109.4
|
)
|
|
14.3
|
|
||
Net cash used in operating activities
|
(117.9
|
)
|
|
(13.7
|
)
|
||
INVESTING ACTIVITIES
|
|
|
|
||||
Capital expenditures
|
(14.4
|
)
|
|
(12.7
|
)
|
||
Other investing activities
|
(3.2
|
)
|
|
2.9
|
|
||
Net cash used in investing activities from continuing operations
|
(17.6
|
)
|
|
(9.8
|
)
|
||
Net cash used in investing activities from discontinued operations
|
(0.2
|
)
|
|
(2.4
|
)
|
||
Net cash used in investing activities
|
(17.8
|
)
|
|
(12.2
|
)
|
||
FINANCING ACTIVITIES
|
|
|
|
||||
Borrowings under credit arrangements
|
1.3
|
|
|
1.6
|
|
||
Repayments under credit arrangements
|
(3.1
|
)
|
|
(13.0
|
)
|
||
Share repurchases
|
(0.7
|
)
|
|
(0.9
|
)
|
||
Proceeds from exercise of stock options
|
3.5
|
|
|
3.5
|
|
||
Other financing activities
|
(0.2
|
)
|
|
—
|
|
||
Net cash provided by (used in) financing activities from continuing operations
|
0.8
|
|
|
(8.8
|
)
|
||
Net cash provided by financing activities from discontinued operations
|
—
|
|
|
0.4
|
|
||
Net cash provided by (used in) financing activities
|
0.8
|
|
|
(8.4
|
)
|
||
Effect of currency exchange rate changes on cash and cash equivalents
|
6.3
|
|
|
2.8
|
|
||
Decrease in cash and cash equivalents
|
(128.6
|
)
|
|
(31.5
|
)
|
||
Cash and cash equivalents, beginning of period
|
721.5
|
|
|
163.3
|
|
||
Cash and cash equivalents, end of period
|
592.9
|
|
|
131.8
|
|
||
Less: Cash and cash equivalents of discontinued operations
|
—
|
|
|
22.3
|
|
||
Cash and cash equivalents of continuing operations, end of period
|
$
|
592.9
|
|
|
$
|
109.5
|
|
Supplemental disclosure of non-cash financing activities:
|
|
|
|
|
|||
Deferred financing costs included in accrued expenses
|
$
|
7.6
|
|
|
$
|
—
|
|
(In millions)
|
March 31,
2018 |
|
December 31,
2017 |
||||
Raw materials
|
$
|
48.2
|
|
|
$
|
41.9
|
|
In process
|
4.4
|
|
|
3.5
|
|
||
Finished products and other
|
62.0
|
|
|
60.9
|
|
||
Total inventories
|
$
|
114.6
|
|
|
$
|
106.3
|
|
(In millions)
|
March 31,
2018 |
|
December 31,
2017 |
||||
9.5% Senior Notes due in 2023, net of unamortized debt issuance costs of $6.1 at March 31, 2018 and $6.4 at December 31, 2017.
|
$
|
518.9
|
|
|
$
|
518.6
|
|
Other borrowings
(1)
|
24.0
|
|
|
25.7
|
|
||
Total debt
|
542.9
|
|
|
544.3
|
|
||
Less debt payable within one year
|
22.5
|
|
|
24.0
|
|
||
Debt payable after one year
|
$
|
520.4
|
|
|
$
|
520.3
|
|
Weighted average interest rates on total debt obligations
|
9.4
|
%
|
|
9.4
|
%
|
|
(In millions)
|
||
2018
|
$
|
22.5
|
|
2019
|
1.0
|
|
|
2020
|
0.5
|
|
|
2021
|
—
|
|
|
2022
|
—
|
|
|
Thereafter
|
518.9
|
|
|
Total debt
|
$
|
542.9
|
|
|
March 31, 2018
|
|
December 31, 2017
|
||||||||||||
(In millions)
|
Carrying Amount
|
|
Fair Value
|
|
Carrying Amount
|
|
Fair Value
|
||||||||
9.5% Senior Notes due in 2023
|
$
|
518.9
|
|
|
$
|
577.9
|
|
|
$
|
518.6
|
|
|
$
|
584.5
|
|
Other borrowings
|
24.0
|
|
|
24.0
|
|
|
25.7
|
|
|
25.7
|
|
||||
Total debt
|
$
|
542.9
|
|
|
$
|
601.9
|
|
|
$
|
544.3
|
|
|
$
|
610.2
|
|
(In millions)
|
March 31,
2018 |
|
December 31,
2017 |
||||
Overfunded defined benefit pension plans
|
$
|
27.9
|
|
|
$
|
26.4
|
|
Underfunded defined benefit pension plans
|
(24.7
|
)
|
|
(26.6
|
)
|
||
Unfunded defined benefit pension plans
|
(31.5
|
)
|
|
(30.5
|
)
|
||
Total underfunded and unfunded defined benefit pension plans
|
(56.2
|
)
|
|
(57.1
|
)
|
||
Pension liabilities included in other current liabilities
|
(1.1
|
)
|
|
(1.0
|
)
|
||
Net funded status
|
$
|
(29.4
|
)
|
|
$
|
(31.7
|
)
|
|
Three Months Ended March 31,
|
||||||||||||||
|
2018
|
|
2017
|
||||||||||||
|
Pension
|
|
Pension
|
||||||||||||
(In millions)
|
U.S.
|
|
Non-U.S.
|
|
U.S.
|
|
Non-U.S.
|
||||||||
Service cost
|
$
|
2.0
|
|
|
$
|
0.8
|
|
|
$
|
1.9
|
|
|
$
|
1.0
|
|
Interest cost
|
1.4
|
|
|
1.4
|
|
|
1.5
|
|
|
1.5
|
|
||||
Expected return on plan assets
|
(1.9
|
)
|
|
(1.8
|
)
|
|
(1.4
|
)
|
|
(1.7
|
)
|
||||
Net periodic benefit cost
|
$
|
1.5
|
|
|
$
|
0.4
|
|
|
$
|
2.0
|
|
|
$
|
0.8
|
|
Less: Discontinued operations net periodic benefit cost
|
—
|
|
|
—
|
|
|
—
|
|
|
0.2
|
|
||||
Net periodic benefit cost from continuing operations
|
$
|
1.5
|
|
|
$
|
0.4
|
|
|
$
|
2.0
|
|
|
$
|
0.6
|
|
(In millions)
|
March 31,
2018 |
|
December 31,
2017 |
||||
Other Current Assets:
|
|
|
|
||||
Non-trade receivables
|
$
|
26.3
|
|
|
$
|
28.4
|
|
Prepaid expenses and other current assets
|
11.7
|
|
|
13.8
|
|
||
Income taxes receivable
|
7.9
|
|
|
6.0
|
|
||
Marketable securities
|
0.4
|
|
|
0.4
|
|
||
Total other current assets
|
$
|
46.3
|
|
|
$
|
48.6
|
|
(In millions)
|
March 31,
2018 |
|
December 31,
2017 |
||||
Other Current Liabilities:
|
|
|
|
||||
Customer volume rebates
|
$
|
23.9
|
|
|
$
|
31.5
|
|
Accrued compensation
(1)
|
21.6
|
|
|
27.1
|
|
||
Income taxes payable
(2)
|
30.2
|
|
|
115.1
|
|
||
Accrued interest
|
8.4
|
|
|
20.8
|
|
||
Pension liabilities
|
1.1
|
|
|
1.0
|
|
||
Restructuring liability
|
10.6
|
|
|
12.8
|
|
||
Other accrued liabilities
(3)
|
96.7
|
|
|
107.9
|
|
||
Total other current liabilities
|
$
|
192.5
|
|
|
$
|
316.2
|
|
(1)
|
Accrued compensation presented in the table above includes salaries and wages, as well as estimated current amounts due under the annual and long-term employee incentive programs.
|
(2)
|
The change in income taxes payable between March 31, 2018 and December 31, 2017 is related primarily to the payment of the Company's 2017 domestic income tax liability.
|
(3)
|
Other accrued liabilities presented in the table above as of March 31, 2018 and December 31, 2017 include
$43.1 million
and
$55.1 million
, respectively, representing the current portion of the liability related to the delayed closings associated with the Company's divestiture of Darex, as discussed in Note 15, "Discontinued Operations."
|
|
Three Months Ended March 31,
|
||||||
(In millions)
|
2018
|
|
2017
|
||||
Severance and other employee costs
|
$
|
0.2
|
|
|
$
|
0.8
|
|
Asset impairments
|
0.4
|
|
|
0.3
|
|
||
Total restructuring and asset impairments
|
$
|
0.6
|
|
|
$
|
1.1
|
|
Less: restructuring and asset impairments reflected in discontinued operations
|
1.1
|
|
|
—
|
|
||
Total restructuring and asset impairments from continuing operations
|
$
|
(0.5
|
)
|
|
$
|
1.1
|
|
|
Three Months Ended March 31,
|
||||||
(In millions)
|
2018
|
|
2017
|
||||
SCC
|
$
|
(0.4
|
)
|
|
$
|
0.8
|
|
SBM
|
(0.5
|
)
|
|
0.3
|
|
||
Corporate
|
0.4
|
|
|
—
|
|
||
Total restructuring and asset impairments from continuing operations
|
$
|
(0.5
|
)
|
|
$
|
1.1
|
|
Restructuring and asset impairments reflected in discontinued operations
|
1.1
|
|
|
—
|
|
||
Total restructuring and asset impairments
|
$
|
0.6
|
|
|
$
|
1.1
|
|
|
2017 Plan
|
|
|
|
|
||||||||||
(In millions)
|
Severance and other employee costs
|
|
Facility exit costs
|
|
Other plans
|
|
Total
|
||||||||
Balance, December 31, 2017
|
$
|
11.6
|
|
|
$
|
0.1
|
|
|
$
|
1.1
|
|
|
$
|
12.8
|
|
Expense
(1)
|
(0.1
|
)
|
|
—
|
|
|
0.3
|
|
|
0.2
|
|
||||
Payments
|
(2.4
|
)
|
|
(0.1
|
)
|
|
(0.1
|
)
|
|
(2.6
|
)
|
||||
Impact of foreign currency and other
|
0.1
|
|
|
—
|
|
|
0.1
|
|
|
0.2
|
|
||||
Balance, March 31, 2018
|
$
|
9.2
|
|
|
$
|
—
|
|
|
$
|
1.4
|
|
|
$
|
10.6
|
|
(1)
|
Asset impairment charges are recorded as a reduction to "Properties and equipment, net" on the accompanying unaudited Consolidated Balance Sheets. These expenses are not recorded to the restructuring liability; and therefore, are not included in the table above.
|
|
Three Months Ended March 31,
|
||
(In millions)
|
2017
|
||
Professional fees
|
$
|
1.4
|
|
Software and IT implementation fees
|
0.3
|
|
|
Employee-related costs
|
0.3
|
|
|
Total
|
$
|
2.0
|
|
|
Three Months Ended March 31, 2018
|
||||||||||
(In millions)
|
Pre-Tax Amount
|
|
Tax (Expense)/
Benefit
|
|
After-Tax Amount
|
||||||
Currency translation adjustments
|
$
|
14.3
|
|
|
$
|
—
|
|
|
$
|
14.3
|
|
Other comprehensive income attributable to GCP shareholders
|
$
|
14.3
|
|
|
$
|
—
|
|
|
$
|
14.3
|
|
|
Three Months Ended March 31, 201
7
|
||||||||||
(In millions)
|
Pre-Tax Amount
|
|
Tax (Expense)/
Benefit
|
|
After-Tax Amount
|
||||||
Currency translation adjustments
|
$
|
12.6
|
|
|
$
|
—
|
|
|
$
|
12.6
|
|
Other comprehensive income attributable to GCP shareholders
|
$
|
12.6
|
|
|
$
|
—
|
|
|
$
|
12.6
|
|
(In millions)
|
Defined Benefit Pension and Other Postretirement Plans
|
|
Currency Translation Adjustments
|
|
Hedging Activities
|
|
Total
|
||||||||
Balance, December 31, 2017
|
$
|
0.4
|
|
|
$
|
(86.0
|
)
|
|
$
|
(0.1
|
)
|
|
$
|
(85.7
|
)
|
Other comprehensive income before reclassifications
|
—
|
|
|
14.3
|
|
|
0.1
|
|
|
14.4
|
|
||||
Amounts reclassified from accumulated other comprehensive income
|
—
|
|
|
—
|
|
|
(0.1
|
)
|
|
(0.1
|
)
|
||||
Net current-period other comprehensive income
|
—
|
|
|
14.3
|
|
|
—
|
|
|
14.3
|
|
||||
Balance, March 31, 2018
|
$
|
0.4
|
|
|
$
|
(71.7
|
)
|
|
$
|
(0.1
|
)
|
|
$
|
(71.4
|
)
|
(In millions)
|
Defined Benefit Pension and Other Postretirement Plans
|
|
Currency Translation Adjustments
|
|
Hedging Activities
|
|
Total
|
||||||||
Balance, December 31, 2016
|
$
|
0.1
|
|
|
$
|
(147.7
|
)
|
|
$
|
—
|
|
|
$
|
(147.6
|
)
|
Other comprehensive income before reclassifications
|
—
|
|
|
12.6
|
|
|
0.1
|
|
|
12.7
|
|
||||
Amounts reclassified from accumulated other comprehensive income
|
—
|
|
|
—
|
|
|
(0.1
|
)
|
|
(0.1
|
)
|
||||
Net current-period other comprehensive income
|
—
|
|
|
12.6
|
|
|
—
|
|
|
12.6
|
|
||||
Balance, March 31, 2017
|
$
|
0.1
|
|
|
$
|
(135.1
|
)
|
|
$
|
—
|
|
|
$
|
(135.0
|
)
|
|
Three Months Ended March 31,
|
||
Assumptions used to calculate expense for stock options:
|
2018
|
|
2017
|
Risk-free interest rate
|
2.71 - 2.80%
|
|
1.95 - 2.10%
|
Average life of options (years)
|
5.5 - 6.5
|
|
5.5 - 6.5
|
Volatility
|
27.91 - 30.65%
|
|
31.42 - 31.96%
|
Dividend yield
|
—
|
|
—
|
Average fair value per stock option
|
$11.07
|
|
$9.13
|
Stock Option Activity
|
Number Of
Shares (in thousands) |
|
Weighted
Average Exercise Price |
|
Weighted
Average Remaining Contractual Term (years) |
|
Aggregated
Intrinsic Value (in thousands) |
|||||
Outstanding, December 31, 2017
|
1,636
|
|
|
$
|
18.94
|
|
|
3.78
|
|
$
|
21,597
|
|
Options exercised
|
209
|
|
|
16.31
|
|
|
|
|
|
|
||
Options forfeited/expired/canceled
|
6
|
|
|
27.25
|
|
|
|
|
|
|
||
Options granted
|
195
|
|
|
32.60
|
|
|
|
|
|
|
||
Outstanding, March 31, 2018
|
1,616
|
|
|
$
|
20.89
|
|
|
4.24
|
|
$
|
13,879
|
|
Exercisable, March 31, 2018
|
906
|
|
|
$
|
18.63
|
|
|
3.28
|
|
$
|
9,442
|
|
Vested and expected to vest, March 31, 2018
|
1,588
|
|
|
$
|
20.82
|
|
|
4.19
|
|
$
|
13,747
|
|
RSU Activity
|
Number Of
Shares (in thousands) |
|
Weighted
Average Grant Date Fair Value |
|||
Outstanding, December 31, 2017
|
406
|
|
|
$
|
19.15
|
|
RSUs settled
|
63
|
|
|
20.44
|
|
|
RSUs forfeited
|
5
|
|
|
28.40
|
|
|
RSUs granted
|
66
|
|
|
32.60
|
|
|
RSUs outstanding, March 31, 2018
|
404
|
|
|
$
|
21.04
|
|
Year
|
|
Number of Shares Vesting (in thousands)
|
|
Settled in Cash
|
|
Settled in Stock
|
2018
|
|
95
|
|
44%
|
|
56%
|
2019
|
|
240
|
|
—%
|
|
100%
|
2020
|
|
46
|
|
—%
|
|
100%
|
2021
|
|
23
|
|
—%
|
|
100%
|
|
Three Months Ended March 31,
|
||
Assumptions used to calculate expense for PBUs:
|
2018
|
|
2017
|
Expected Term (Remaining Performance Period)
|
2.86 years
|
|
2.84 years
|
Expected volatility
|
28.56%
|
|
28.00%
|
Risk-free interest rate
|
2.38%
|
|
1.41%
|
Expected dividends
|
—
|
|
—
|
Correlation coefficient
|
38.98%
|
|
46.83%
|
Average correlation coefficient of constituents
|
39.96%
|
|
42.33%
|
|
Three Months Ended March 31,
|
||||||
(In millions, except per share amounts)
|
2018
|
|
2017
|
||||
Numerators
|
|
|
|
||||
Loss from continuing operations attributable to GCP shareholders
|
$
|
(13.8
|
)
|
|
$
|
(25.0
|
)
|
Income from discontinued operations, net of income taxes
|
7.2
|
|
|
8.1
|
|
||
Net loss attributable to GCP shareholders
|
$
|
(6.6
|
)
|
|
$
|
(16.9
|
)
|
Denominators
|
|
|
|
||||
Weighted average common shares—basic calculation
|
71.9
|
|
|
71.2
|
|
||
Dilutive effect of employee stock awards
(1)
|
—
|
|
|
—
|
|
||
Weighted average common shares—diluted calculation
|
71.9
|
|
|
71.2
|
|
||
Basic (loss) earnings per share
|
|
|
|
||||
Loss from continuing operations attributable to GCP shareholders
|
$
|
(0.19
|
)
|
|
$
|
(0.35
|
)
|
Income from discontinued operations, net of income taxes
|
$
|
0.10
|
|
|
$
|
0.11
|
|
Net loss attributable to GCP shareholders
(2)
|
$
|
(0.09
|
)
|
|
$
|
(0.24
|
)
|
Diluted (loss) earnings per share
|
|
|
|
||||
Loss from continuing operations attributable to GCP shareholders
|
$
|
(0.19
|
)
|
|
$
|
(0.35
|
)
|
Income from discontinued operations, net of income taxes
|
$
|
0.10
|
|
|
$
|
0.11
|
|
Net loss attributable to GCP shareholders
(2)
|
$
|
(0.09
|
)
|
|
$
|
(0.24
|
)
|
(1)
|
Dilutive effect only applicable to periods in which GCP generated income from continuing operations.
|
(2)
|
Amounts may not sum due to rounding.
|
|
Three Months Ended March 31,
|
||||||
(In millions)
|
2018
|
|
2017
|
||||
Net Sales
|
|
|
|
||||
Specialty Construction Chemicals
|
$
|
147.0
|
|
|
$
|
134.0
|
|
Specialty Building Materials
|
103.2
|
|
|
91.3
|
|
||
Total net sales
|
$
|
250.2
|
|
|
$
|
225.3
|
|
Segment Operating Income
|
|
|
|
||||
Specialty Construction Chemicals segment operating income
|
$
|
5.9
|
|
|
$
|
8.6
|
|
Specialty Building Materials segment operating income
|
18.1
|
|
|
15.2
|
|
||
Total segment operating income
|
$
|
24.0
|
|
|
$
|
23.8
|
|
|
Three Months Ended March 31,
|
||||||
(In millions)
|
2018
|
|
2017
|
||||
Total segment operating income
|
$
|
24.0
|
|
|
$
|
23.8
|
|
Corporate costs
(1)
|
(8.9
|
)
|
|
(10.2
|
)
|
||
Certain pension costs
|
(1.9
|
)
|
|
(2.6
|
)
|
||
Repositioning expenses
|
(0.9
|
)
|
|
(2.0
|
)
|
||
Restructuring and asset impairments
|
0.5
|
|
|
(1.1
|
)
|
||
Third-party and other acquisition-related costs
|
(0.8
|
)
|
|
(0.4
|
)
|
||
Amortization of acquired inventory fair value adjustment
|
—
|
|
|
(1.5
|
)
|
||
Tax indemnification adjustments
|
—
|
|
|
(2.4
|
)
|
||
Net income attributable to noncontrolling interests
|
0.1
|
|
|
—
|
|
||
Interest expense, net
|
(12.3
|
)
|
|
(17.0
|
)
|
||
Loss from continuing operations before income taxes
|
$
|
(0.2
|
)
|
|
$
|
(13.4
|
)
|
(1)
|
Management allocates corporate costs to each segment to the extent such costs are directly attributable to the segments. Corporate costs include approximately
$3.0 million
of allocated costs during the three months ended March 31, 2017 that were previously reported within the Darex operating segment since such costs did not meet the criteria to be reclassified to discontinued operations. As of the third quarter of 2017, the Company began allocating these costs to its remaining operating segments.
|
|
Three Months Ended March 31,
|
||||||
(In millions)
|
2018
|
|
2017
|
||||
Net Sales
|
|
|
|
||||
United States
|
$
|
116.9
|
|
|
$
|
106.8
|
|
Canada and Puerto Rico
|
6.1
|
|
|
5.1
|
|
||
Total North America
|
123.0
|
|
|
111.9
|
|
||
Europe Middle East Africa
|
58.3
|
|
|
45.5
|
|
||
Asia Pacific
|
52.0
|
|
|
51.2
|
|
||
Latin America
|
16.9
|
|
|
16.7
|
|
||
Total
|
$
|
250.2
|
|
|
$
|
225.3
|
|
(In millions)
|
|
||
Net proceeds included in gain recognized in 2018
|
$
|
25.0
|
|
Less: Net assets derecognized in 2018
|
6.5
|
|
|
Gain recognized in 2018 before income taxes
|
18.5
|
|
|
Less: Tax effect of gain recognized in 2018
|
8.2
|
|
|
Gain recognized in 2018 after income taxes
|
$
|
10.3
|
|
|
Three Months Ended March 31,
|
||||||
(In millions)
|
2018
|
|
2017
|
||||
Net sales
|
$
|
5.7
|
|
|
$
|
71.8
|
|
Cost of goods sold
|
7.1
|
|
|
45.2
|
|
||
Selling, general and administrative expenses
|
1.8
|
|
|
14.8
|
|
||
Research and development expenses
|
—
|
|
|
1.1
|
|
||
Restructuring and asset impairments
|
1.1
|
|
|
—
|
|
||
Gain on sale of business
|
(18.5
|
)
|
|
—
|
|
||
Other (income) expense, net
|
(0.2
|
)
|
|
0.8
|
|
||
Provision for income taxes
|
(7.2
|
)
|
|
(1.8
|
)
|
||
Income from discontinued operations, net of income taxes
|
$
|
7.2
|
|
|
$
|
8.1
|
|
(In millions)
|
March 31, 2018
|
|
December 31, 2017
|
||||
Trade accounts receivable
|
$
|
4.1
|
|
|
$
|
8.4
|
|
Inventories
|
3.5
|
|
|
10.6
|
|
||
Other current assets
|
0.5
|
|
|
0.7
|
|
||
Current assets held for sale
|
$
|
8.1
|
|
|
$
|
19.7
|
|
Properties and equipment, net
|
1.9
|
|
|
2.2
|
|
||
Other assets
|
0.1
|
|
|
0.6
|
|
||
Non-current assets held for sale
|
$
|
2.0
|
|
|
$
|
2.8
|
|
Accounts payable
|
3.4
|
|
|
6.4
|
|
||
Other current liabilities
|
0.9
|
|
|
1.4
|
|
||
Current liabilities held for sale
|
$
|
4.3
|
|
|
$
|
7.8
|
|
Underfunded and unfunded defined benefit pension plans
|
0.3
|
|
|
0.3
|
|
||
Non-current liabilities held for sale
|
$
|
0.3
|
|
|
$
|
0.3
|
|
(In millions)
|
Net Assets Acquired
|
||
Accounts receivable
|
$
|
2.2
|
|
Other current assets
|
0.2
|
|
|
Properties and equipment
|
0.1
|
|
|
Goodwill
|
14.0
|
|
|
Intangible assets
|
15.5
|
|
|
Accounts payable
|
(0.2
|
)
|
|
Net assets acquired
|
$
|
31.8
|
|
•
|
Specialty Construction Chemicals.
Our Specialty Construction Chemicals ("SCC") operating segment provides products, technologies, and services that reduce the cost and improve the performance and quality of cement, concrete, mortar, masonry and other cementitious-based construction materials.
|
•
|
Specialty Building Materials.
Our Specialty Building Materials ("SBM") operating segment produces and sells sheet and liquid membrane systems and other products that protect both new and existing structures from water, air, and vapor penetration, as well as from fire damage. We also manufacture and sell specialized cementitious and chemical grouts used for soil consolidation and leak-sealing applications in addition to a moisture barrier system and installation tools for the flooring industry.
|
•
|
Net sales
increase
d
11.1%
to
$250.2 million
.
|
•
|
Loss from continuing operations attributable to GCP shareholders was
$13.8 million
, or
$0.19
per diluted share, compared to
$25.0 million
, or
$0.35
per diluted share, for the prior-year quarter.
|
•
|
Adjusted EBIT
increase
d
20.0%
to
$13.2 million
.
|
•
|
Adjusted EPS was
$0.01
per diluted share compared to
$(0.06)
in the prior-year quarter.
|
•
|
Adjusted EBIT Return On Invested Capital was
20.2%
on a trailing four quarters basis compared with
25.9%
for the
2017
first quarter
.
|
Analysis of Operations
(In millions, except per share amounts) |
Three Months Ended March 31,
|
|||||||||
2018
|
|
2017
|
|
% Change
|
||||||
Net sales:
|
|
|
|
|
|
|||||
Specialty Construction Chemicals
|
$
|
147.0
|
|
|
$
|
134.0
|
|
|
9.7
|
%
|
Specialty Building Materials
|
103.2
|
|
|
91.3
|
|
|
13.0
|
%
|
||
Total GCP net sales
|
$
|
250.2
|
|
|
$
|
225.3
|
|
|
11.1
|
%
|
Net sales by region:
|
|
|
|
|
|
|||||
North America
|
$
|
123.0
|
|
|
$
|
111.9
|
|
|
9.9
|
%
|
Europe Middle East Africa (EMEA)
|
58.3
|
|
|
45.5
|
|
|
28.1
|
%
|
||
Asia Pacific
|
52.0
|
|
|
51.2
|
|
|
1.6
|
%
|
||
Latin America
|
16.9
|
|
|
16.7
|
|
|
1.2
|
%
|
||
Total net sales by region
|
$
|
250.2
|
|
|
$
|
225.3
|
|
|
11.1
|
%
|
|
|
|
|
|
|
|||||
Profitability performance measures:
|
|
|
|
|
|
|||||
Adjusted EBIT(A):
|
|
|
|
|
|
|||||
Specialty Construction Chemicals segment operating income
|
$
|
5.9
|
|
|
$
|
8.6
|
|
|
(31.4
|
)%
|
Specialty Building Materials segment operating income
|
18.1
|
|
|
15.2
|
|
|
19.1
|
%
|
||
Corporate costs(B)
|
(8.9
|
)
|
|
(10.2
|
)
|
|
12.7
|
%
|
||
Certain pension costs(C)
|
(1.9
|
)
|
|
(2.6
|
)
|
|
26.9
|
%
|
||
Adjusted EBIT (non-GAAP)
|
13.2
|
|
|
11.0
|
|
|
20.0
|
%
|
||
Repositioning expenses
|
(0.9
|
)
|
|
(2.0
|
)
|
|
55.0
|
%
|
||
Restructuring and asset impairments
|
0.5
|
|
|
(1.1
|
)
|
|
NM
|
|
||
Third-party and other acquisition-related costs
|
(0.8
|
)
|
|
(0.4
|
)
|
|
(100.0
|
)%
|
||
Amortization of acquired inventory fair value adjustment
|
—
|
|
|
(1.5
|
)
|
|
NM
|
|
||
Tax indemnification adjustments
|
—
|
|
|
(2.4
|
)
|
|
NM
|
|
||
Interest expense, net
|
(12.3
|
)
|
|
(17.0
|
)
|
|
27.6
|
%
|
||
Income tax expense
|
(13.5
|
)
|
|
(11.6
|
)
|
|
(16.4
|
)%
|
||
Loss from continuing operations attributable to GCP shareholders (GAAP)
|
$
|
(13.8
|
)
|
|
$
|
(25.0
|
)
|
|
44.8
|
%
|
Diluted EPS from continuing operations (GAAP)
|
$
|
(0.19
|
)
|
|
$
|
(0.35
|
)
|
|
45.7
|
%
|
Adjusted EPS (non-GAAP)
|
$
|
0.01
|
|
|
$
|
(0.06
|
)
|
|
NM
|
|
Analysis of Operations
(In millions) |
Three Months Ended March 31,
|
|||||||||
2018
|
|
2017
|
|
% Change
|
||||||
Adjusted profitability performance measures:
|
|
|
|
|
|
|
|
|
||
Gross Profit:
|
|
|
|
|
|
|
|
|
||
Specialty Construction Chemicals
|
$
|
46.0
|
|
|
$
|
47.8
|
|
|
(3.8
|
)%
|
Specialty Building Materials
|
41.9
|
|
|
39.5
|
|
|
6.1
|
%
|
||
Adjusted Gross Profit (non-GAAP)
|
87.9
|
|
|
87.3
|
|
|
0.7
|
%
|
||
Amortization of acquired inventory fair value adjustment
|
—
|
|
|
(1.5
|
)
|
|
NM
|
|
||
Corporate costs and pension costs in cost of goods sold
|
(0.4
|
)
|
|
(0.5
|
)
|
|
20.0
|
%
|
||
Total GCP Gross Profit (GAAP)
|
87.5
|
|
|
85.3
|
|
|
2.6
|
%
|
||
Gross Margin:
|
|
|
|
|
|
|
|
|
||
Specialty Construction Chemicals
|
31.3
|
%
|
|
35.7
|
%
|
|
(4.4) pts
|
|||
Specialty Building Materials
|
40.6
|
%
|
|
43.3
|
%
|
|
(2.7) pts
|
|||
Adjusted Gross Margin (non-GAAP)
|
35.1
|
%
|
|
38.7
|
%
|
|
(3.6) pts
|
|||
Amortization of acquired inventory fair value adjustment
|
—
|
%
|
|
(0.7
|
)%
|
|
0.7 pts
|
|||
Corporate costs and pension costs in cost of goods sold
|
(0.2
|
)%
|
|
(0.2
|
)%
|
|
0.0 pts
|
|||
Total GCP Gross Margin (GAAP)
|
34.9
|
%
|
|
37.8
|
%
|
|
(2.9) pts
|
|||
Adjusted EBIT(A)(B)(C):
|
|
|
|
|
|
|
|
|
||
Specialty Construction Chemicals segment operating income
|
$
|
5.9
|
|
|
$
|
8.6
|
|
|
(31.4
|
)%
|
Specialty Building Materials segment operating income
|
18.1
|
|
|
15.2
|
|
|
19.1
|
%
|
||
Corporate and certain pension costs
|
(10.8
|
)
|
|
(12.8
|
)
|
|
15.6
|
%
|
||
Total GCP Adjusted EBIT (non-GAAP)
|
13.2
|
|
|
11.0
|
|
|
20.0
|
%
|
||
Depreciation and amortization:
|
|
|
|
|
|
|
|
|
||
Specialty Construction Chemicals
|
$
|
6.0
|
|
|
$
|
5.1
|
|
|
17.6
|
%
|
Specialty Building Materials
|
3.4
|
|
|
2.9
|
|
|
17.2
|
%
|
||
Corporate
|
0.8
|
|
|
0.4
|
|
|
100.0
|
%
|
||
Total GCP depreciation and amortization
|
10.2
|
|
|
8.4
|
|
|
21.4
|
%
|
||
Adjusted EBITDA:
|
|
|
|
|
|
|
|
|
||
Specialty Construction Chemicals
|
$
|
11.9
|
|
|
$
|
13.7
|
|
|
(13.1
|
)%
|
Specialty Building Materials
|
21.5
|
|
|
18.1
|
|
|
18.8
|
%
|
||
Corporate and certain pension costs
|
(10.0
|
)
|
|
(12.4
|
)
|
|
19.4
|
%
|
||
Total GCP Adjusted EBITDA (non-GAAP)
|
23.4
|
|
|
19.4
|
|
|
20.6
|
%
|
||
Adjusted EBIT Margin:
|
|
|
|
|
|
|
|
|
||
Specialty Construction Chemicals
|
4.0
|
%
|
|
6.4
|
%
|
|
(2.4) pts
|
|||
Specialty Building Materials
|
17.5
|
%
|
|
16.6
|
%
|
|
0.9 pts
|
|||
Total GCP Adjusted EBIT Margin (non-GAAP)
|
5.3
|
%
|
|
4.9
|
%
|
|
0.4 pts
|
|||
Adjusted EBITDA Margin:
|
|
|
|
|
|
|
|
|
||
Specialty Construction Chemicals
|
8.1
|
%
|
|
10.2
|
%
|
|
(2.1) pts
|
|||
Specialty Building Materials
|
20.8
|
%
|
|
19.8
|
%
|
|
1.0 pts
|
|||
Total GCP Adjusted EBITDA Margin (non-GAAP)
|
9.4
|
%
|
|
8.6
|
%
|
|
0.8 pts
|
Analysis of Operations
(In millions)
|
Four Quarters Ended
|
||||||
March 31, 2018
|
|
March 31, 2017
|
|||||
Calculation of Adjusted EBIT Return On Invested Capital (trailing four quarters):
|
|||||||
Adjusted EBIT
|
$
|
129.6
|
|
|
$
|
125.3
|
|
Invested Capital:
|
|
|
|
|
|
||
Trade accounts receivable
|
194.6
|
|
|
169.4
|
|
||
Inventories
|
114.6
|
|
|
101.3
|
|
||
Accounts payable
|
(133.7
|
)
|
|
(104.7
|
)
|
||
Invested working capital
|
175.5
|
|
|
166.0
|
|
||
Other current assets (excluding income taxes)
|
38.4
|
|
|
35.0
|
|
||
Properties and equipment, net
|
220.1
|
|
|
191.5
|
|
||
Goodwill
|
202.9
|
|
|
115.1
|
|
||
Technology and other intangible assets, net
|
91.1
|
|
|
51.0
|
|
||
Other assets (excluding capitalized financing fees)
|
26.7
|
|
|
19.7
|
|
||
Other current liabilities (excluding income taxes, restructuring, repositioning, accrued interest and liabilities incurred in association with the Darex divestiture)
|
(95.7
|
)
|
|
(81.4
|
)
|
||
Other liabilities (excluding other postretirement benefits liability and liabilities incurred in association with the Darex divestiture)
|
(18.6
|
)
|
|
(13.8
|
)
|
||
Total invested capital
|
$
|
640.4
|
|
|
$
|
483.1
|
|
Adjusted EBIT Return On Invested Capital (non-GAAP)
|
20.2
|
%
|
|
25.9
|
%
|
(A)
|
Our segment operating income includes only our share of income of consolidated joint ventures.
|
(B)
|
Management allocates corporate costs to each segment to the extent such costs are directly attributable to the segments. Corporate costs include approximately
$3.0 million
of allocated costs in the three months ended March 31, 2017 that were previously reported within the Darex operating segment since such costs did not meet the criteria to be reclassified to discontinued operations. As of the third quarter of 2017, we began allocating these costs to its remaining operating segments.
|
(C)
|
Certain pension costs include only ongoing costs recognized quarterly, which include service and interest costs, expected returns on plan assets and amortization of prior service costs/credits. SCC and SBM segment operating income and corporate costs do not include any amounts for pension expense. Other pension-related costs including annual mark-to-market adjustments, actuarial gains and losses, gains or losses from curtailments and terminations and other related costs are excluded from Adjusted EBIT. These amounts are not used by management to evaluate the performance of our businesses and significantly affect the peer-to-peer and period-to-period comparability of our financial results. Mark-to-market adjustments, actuarial gains and losses and other related costs relate primarily to changes in financial market values and actuarial assumptions and are not directly related to the operation of our businesses.
|
NM
|
Not meaningful.
|
|
Three Months Ended March 31,
|
||||||||||||||||||||||||||||||
|
2018
|
|
2017
|
||||||||||||||||||||||||||||
(In millions, except per share amounts)
|
Pre-
Tax
|
|
Tax Effect
|
|
After-
Tax
|
|
Per
Share
|
|
Pre-
Tax
|
|
Tax Effect
|
|
After-
Tax
|
|
Per
Share
|
||||||||||||||||
Diluted EPS from continuing operations (GAAP)
|
|
|
|
|
|
|
|
|
|
$
|
(0.19
|
)
|
|
|
|
|
|
|
|
|
|
|
$
|
(0.35
|
)
|
||||||
Repositioning expenses
|
$
|
0.9
|
|
|
$
|
0.2
|
|
|
$
|
0.7
|
|
|
0.01
|
|
|
$
|
2.0
|
|
|
$
|
0.8
|
|
|
$
|
1.2
|
|
|
0.02
|
|
||
Restructuring and asset impairments
|
(0.5
|
)
|
|
(0.1
|
)
|
|
(0.4
|
)
|
|
(0.01
|
)
|
|
1.1
|
|
|
0.3
|
|
|
0.8
|
|
|
0.01
|
|
||||||||
Third-party and other acquisition-related costs
|
0.8
|
|
|
0.2
|
|
|
0.6
|
|
|
0.01
|
|
|
0.4
|
|
|
0.2
|
|
|
0.2
|
|
|
—
|
|
||||||||
Amortization of acquired inventory fair value adjustment
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
1.5
|
|
|
0.6
|
|
|
0.9
|
|
|
0.01
|
|
||||||||
Tax indemnification adjustments
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
2.4
|
|
|
0.9
|
|
|
1.5
|
|
|
0.02
|
|
||||||||
Discrete tax items:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Discrete tax items, including adjustments to uncertain tax positions
|
—
|
|
|
(13.5
|
)
|
|
13.5
|
|
|
0.19
|
|
|
—
|
|
|
(16.7
|
)
|
|
16.7
|
|
|
0.23
|
|
||||||||
Adjusted EPS (non-GAAP)
|
|
|
|
|
|
|
$
|
0.01
|
|
|
|
|
|
|
|
|
|
|
|
$
|
(0.06
|
)
|
|
Three Months Ended March 31, 2018
as a Percentage Increase (Decrease) from Three Months Ended March 31, 2017 |
||||||||||
Net Sales Variance Analysis
|
Volume
|
|
Price
|
|
Currency Translation
|
|
Total Change
|
||||
Specialty Construction Chemicals
|
5.8
|
%
|
|
0.7
|
%
|
|
3.2
|
%
|
|
9.7
|
%
|
Specialty Building Materials
|
10.6
|
%
|
|
(1.0
|
)%
|
|
3.4
|
%
|
|
13.0
|
%
|
Net sales
|
7.7
|
%
|
|
0.1
|
%
|
|
3.3
|
%
|
|
11.1
|
%
|
By Region:
|
|
|
|
|
|
|
|
||||
North America
|
9.5
|
%
|
|
0.2
|
%
|
|
0.2
|
%
|
|
9.9
|
%
|
Europe Middle East Africa
|
16.7
|
%
|
|
1.3
|
%
|
|
10.1
|
%
|
|
28.1
|
%
|
Asia Pacific
|
(2.4
|
)%
|
|
(1.3
|
)%
|
|
5.3
|
%
|
|
1.6
|
%
|
Latin America
|
2.2
|
%
|
|
—
|
%
|
|
(1.0
|
)%
|
|
1.2
|
%
|
|
Three Months Ended March 31,
|
||||||
(In millions)
|
2018
|
|
2017
|
||||
Severance and other employee costs
|
$
|
0.2
|
|
|
$
|
0.8
|
|
Asset impairments
|
0.4
|
|
|
0.3
|
|
||
Total restructuring and asset impairments
|
$
|
0.6
|
|
|
$
|
1.1
|
|
Less: restructuring and asset impairments reflected in discontinued operations
|
1.1
|
|
|
—
|
|
||
Total restructuring and asset impairments from continuing operations
|
$
|
(0.5
|
)
|
|
$
|
1.1
|
|
|
Three Months Ended March 31,
|
||
(In millions)
|
2017
|
||
Professional fees
|
$
|
1.4
|
|
Software and IT implementation fees
|
0.3
|
|
|
Employee-related costs
|
0.3
|
|
|
Total
|
$
|
2.0
|
|
(In millions) |
Maximum Borrowing Amount
|
|
Available Liquidity
|
|
Expiration Date
|
||||
China
|
$
|
13.6
|
|
|
$
|
5.7
|
|
|
Open end
|
India
|
12.0
|
|
|
2.2
|
|
|
2/3/2021
|
||
Korea
|
5.0
|
|
|
5.0
|
|
|
2/3/2021
|
||
Canada
|
5.8
|
|
|
1.9
|
|
|
2/3/2021
|
||
Brazil
|
2.7
|
|
|
2.7
|
|
|
4/30/2018
|
||
Mexico
|
2.5
|
|
|
2.5
|
|
|
3/31/2019
|
||
United Arab Emirates
|
2.5
|
|
|
2.5
|
|
|
12/31/2018
|
||
Other countries
|
14.6
|
|
|
13.2
|
|
|
Open end
|
||
Total
|
$
|
58.7
|
|
|
$
|
35.7
|
|
|
|
|
Three Months Ended March 31,
|
||||||
(In millions)
|
2018
|
|
2017
|
||||
Net cash used in operating activities from continuing operations
|
$
|
(8.5
|
)
|
|
$
|
(28.0
|
)
|
Net cash used in investing activities from continuing operations
|
(17.6
|
)
|
|
(9.8
|
)
|
||
Net cash provided by (used in) financing activities from continuing operations
|
0.8
|
|
|
(8.8
|
)
|
Exhibit No.
|
|
Description of Exhibit
|
31.1*
|
|
Certification of the Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
31.2*
|
|
Certification of the Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
32**
|
|
Certification of the Chief Executive Officer and Chief Financial Officer under Section 906 of the Sarbanes-Oxley Act of 2002
|
4.1
|
|
Indenture, dated as of April 10, 2018, among GCP Applied Technologies Inc., the guarantors party thereto and Wilmington Trust, National Association, as trustee (incorporated herein by reference to Exhibit 4.1 to GCP’s Current Report on Form 8-K filed on April 10, 2018).
|
4.2
|
|
Form of 5.500% Note due 2026 (included as Exhibit A to Exhibit 4.1) (incorporated herein by reference to Exhibit 4.2 to GCP’s Current Report on Form 8-K filed on April 10, 2018).
|
10.1
|
|
Second Amendment to Credit Agreement, dated as of April 10, 2018, by and among GCP Applied Technologies Inc., GCP Applied Technologies Limited, GCP Applied Technologies N.V., the guarantors party thereto, the lenders party thereto and Deutsche Bank AG New York Branch, as administrative agent (incorporated herein by reference to Exhibit 10.1 to GCP’s Current Report on Form 8-K filed on April 10, 2018).
|
101.INS*
|
|
XBRL Instance Document
|
101.SCH*
|
|
XBRL Taxonomy Extension Schema
|
101.CAL*
|
|
XBRL Taxonomy Extension Calculation Linkbase
|
101.DEF*
|
|
XBRL Taxonomy Extension Definition Linkbase
|
101.LAB*
|
|
XBRL Taxonomy Extension Label Linkbase
|
101.PRE*
|
|
XBRL Taxonomy Extension Presentation Linkbase
|
|
GCP Applied Technologies Inc.
(Registrant)
|
|
|
|
|
Date: May 8, 2018
|
By:
|
/s/ GREGORY E. POLING
|
|
|
Gregory E. Poling
President and Chief Executive Officer
(Principal Executive Officer)
|
|
|
|
Date: May 8, 2018
|
By:
|
/s/ DEAN P. FREEMAN
|
|
|
Dean P. Freeman
Vice President and Chief Financial Officer
(Principal Financial Officer)
|
|
|
|
Date: May 8, 2018
|
By:
|
/s/ KENNETH S. KOROTKIN
|
|
|
Kenneth S. Korotkin
Vice President, Controller and Chief Accounting Officer
(Principal Accounting Officer)
|
Exhibit No.
|
|
Description of Exhibit
|
|
||
|
||
|
||
|
||
|
||
|
||
101.INS*
|
|
XBRL Instance Document
|
101.SCH*
|
|
XBRL Taxonomy Extension Schema
|
101.CAL*
|
|
XBRL Taxonomy Extension Calculation Linkbase
|
101.DEF*
|
|
XBRL Taxonomy Extension Definition Linkbase
|
101.LAB*
|
|
XBRL Taxonomy Extension Label Linkbase
|
101.PRE*
|
|
XBRL Taxonomy Extension Presentation Linkbase
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
---|
DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
---|
No information found
Customers
Customer name | Ticker |
---|---|
Vulcan Materials Company | VMC |
No Suppliers Found
Price
Yield
Owner | Position | Direct Shares | Indirect Shares |
---|